Transforming Global Health with Fearless Science.
EpiVax has been pushing the boundaries of computational immunology for over 25 years, developing broad analytical capabilities that empower pharmaceutical developers to make informed decisions during the preclinical journey of their biologic therapeutics and vaccines. The goal is to aid in the development of treatments that are safer and more effective by offering cutting-edge in silico and in vitro methods.
We believe in the power of science to transform human and animal health outcomes globally. Our industry-leading tools are complemented by an expert team of scientists who bring decades of experience and a collaborative mindset to every project. This combination of expertise and innovation allows us to deliver unparalleled insights and solutions to our clients.
Our clients range from emerging startups to the largest players in the industry who are united by a common mission: improving patient care. We frequently collaborate with regulatory agencies, academia, and leading pharmaceutical companies to ensure that our contributions to science are impactful.
The philosophy of EpiVax is captured in the motto we live by, “Fearless Science.” This phrase represents our commitment to advancing science boldly and bravely, regardless of the challenges we face. It means daring to pursue groundbreaking research and development that has the potential to improve human and animal health across the world. We invite you to join us on this journey towards a healthier future, where science knows no limits.
Founders
Anne De Groot, M.D.
Anne De Groot, M.D.
Annie De Groot is internationally known for her research on the human immune system’s response to vaccines and therapeutics. She graduated from Smith College in 1978 and earned her medical degree at University of Chicago in 1983. After internal medical residency, she obtained advanced training in immunoinformatics and vaccinology with Michael Good, Russell Howard and Jay Berzofsky at the National Institutes of Health, and then returned for a fellowship in ID at New England Medical Center.
Senior Professor (Research), University of Georgia Center for Vaccines and Immunology Founder/Scientific Director GAIA Vaccine Foundation Volunteer Medical Director Clínica Esperanza /Hope Clinic. She then moved to Brown University, establishing the TB/HIV Research Lab as an emerging center for immune-informatics driven Vaccine design. EpiVax spun out from that laboratory in 1998 and she gradually shifted her effort from 20% to 80% effort at the company. In 2008, she was invited to move her academic affiliation from Brown University to University of Rhode Island, in order to establish the Institute for Immunology and Informatics (iCubed). In 2020, Dr. De Groot joined the University of Georgia as a Senior Professor (Research) in the College of Veterinary Medicine/Center for Vaccines and Immunology. She has been the recipient of many awards for her groundbreaking work at the intersection of immunology and informatics and is recognized as an early adopter of this technology and an evangelist for the use of immunoinformatics to improve vaccines and protein therapeutics.
William Martin
William Martin
William Martin is a co-founder and longtime employee of EpiVax.
He is trained in Economics and Business Administration, System Analysis, and Computational Immunology.
In his current role Mr. Martin serves as a consultant to the Chief Information (CIO) and Chief Technology (CTO) officers of EpiVax.
Corporate Responsibility
At EpiVax, we aspire to see beyond the horizon and contribute to something greater than ourselves. To achieve this, we empower every team member to actively participate in building that legacy.
We believe that it is our common responsibility to support the community in which we live and work. Therefore, EpiVax and our team members regularly provide charitable support to local, national and international non-profits financially and through volunteer hours. In 2023, we contributed to more than 25 different organizations in our city and across the world in areas such as animal welfare, disaster recovery, homelessness and food insecurity, the arts, and more. Our dedication to giving back further emphasizes our commitment to improving the lives of others, whether it be through vaccination, therapeutics, or by lending a hand to our neighbors.